Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance

Clinical and Experimental Allergy

Volumn 43, Issue 1, 2013, Pages 85-91

  Blanca Lopez, N ^a   Torres, M J ^b   Dona I ^b   Campo, P ^b   Rondon C ^b   Seoane Reula, M E ^a   Salas, M ^b   Canto, G ^a   Blanca, M ^b  

^a HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Angioedema; ASA drug provocation test; Clinical history; Cross intolerance; Diagnosis; NSAID hypersensitivity; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT RESPONSE; URTICARIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; URTICARIA; YOUNG ADULT;

EID: 84871692504     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12013     Document Type: Article

References (23)

1. Doña I, Blanca-López N, Cornejo-García JA, et al. Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41:86-95.
2. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5:309-16.
3. Szczeklik A, Nizankowska E, Sanak M. Hypersensitivity to aspirin and non-steroidalantiinflammatory drugs. In: Adkinson NF, Bochner BS, Busse WW, Holgate S, Lemanske RF, Simons FE, eds. Middelton′s allergy, principles and practice. 7th edn. Philadelphia: Mosby, 2009:1227-43.
4. Kowlaski ML, Makowska JS, Blanca M, et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)- classification, diagnosis and Management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 2011; 66:818-29.
5. Schneider CH, Kasper MF, de Weck AL, et al. Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione, cross-reactivity relationships. Allergy 1987; 42:597-603.
6. Blanca M, Pérez E, García JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989; 62:295-8.
7. Himly M, Jahn-Schmid B, Pittertschatscher K, et al. IgE mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003; 111:882-8.
8. Scala E, Giani M, Pirrotta L, et al. Selective severe anaphylactic reaction due to ketorolac tromethamine without non-steroidal antiinflammatory drug intolerance. J Allergy Clin Immunol 2001; 107:557.
9. del Pozo MD, Lobera T, Blasco A. Selective hypersensitivity to diclofenaco. Allergy 2000; 55:412-13.
10. del Paramo BJ, Gancedo SQ, Cuevas M, et al. Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol 2000; 85:508-11.
11. Sanchez-Borges M. NSAID Hypersensitivity Respiratory, Cutaneous, and Generalized Anaphylactic Symptoms. Med Clin North Am 2010; 94:853-63.
12. Stevenson DD, Sánchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit ciclooxigenase enzymes. Ann Allergy Asthma Immunol 2001; 87:177-80.
13. Canto MG, Andreu I, Fernández J, Blanca M. Selective immediate hypersensitivity reactions to NSAIDs. Curr Opin Allergy Clin Immunol 2009; 9:293-7.
14. Gómez E, Blanca-López N, Torres MJ, et al. Immunogloblin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-24.
15. Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show a Th1 profile and levels of perforin, granzyme B and Fas-L related to disease severity. J Allergy Clin Immunol 2002; 109:155-61.
16. Sanz ML, Gamboa PM, Mayorga C. Basophil activation test in the evaluation of immediate drug hypersensitivity. Curr Opin Allergy Clin Immunol 2009; 9:298-304.
17. Kowalski ML, Ptasinska A, Jedrzejczak M, et al. Aspirin-triggered 15-HETEgeneration in pepheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test. Allergy 2005; 60:1139-45.
18. Aberer W, Bircher A, Romano A, et al. European Network for Drug Allergy (ENDA); EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58:854-63.
19. Viola M, Rumi G, Valluzi RL, et al. Assesing potencial determinants of positive provocation test in subjects with NSAID hypersensitivity. Clin Exp Allergy 2010; 41:96-103.
20. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation test for diagnosis of aspirin hypersensitivity. Allergy 2007; 62:1111-18.
21. Blanca M, Campo P, Rondon C, et al. Response to Nasal challenge with Lysine-aspirin in subjects with hypersensitivity reactions to NSAIDs with respiratory versus cutaneous involvement. J Allergy Clin Immunol 2011; 127:192.
22. Dursun AB, Woessner KA, Simon RA, et al. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol 2008; 100:420-5.
23. Doña I, Blanca-López N, Jagemann LR, et al. Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011b; 66:1428-33.